Eric Olson

Array ( [id] => 5913632 [patent_doc_number] => 20060128694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders' [patent_app_type] => utility [patent_app_number] => 11/249796 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11578 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128694.pdf [firstpage_image] =>[orig_patent_app_number] => 11249796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727988 [patent_doc_number] => 20080207532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Use of Nordihydroguaiaretic Acid Derivatives in the Treatment of Drug Resistant Cancer, Viral and Microbial Infection' [patent_app_type] => utility [patent_app_number] => 11/664875 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13370 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207532.pdf [firstpage_image] =>[orig_patent_app_number] => 11664875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721256 [patent_doc_number] => 20060074031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'D-pyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture' [patent_app_type] => utility [patent_app_number] => 11/239917 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15164 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074031.pdf [firstpage_image] =>[orig_patent_app_number] => 11239917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479614 [patent_doc_number] => 20090202571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Bioreductively-activated prodrugs' [patent_app_type] => utility [patent_app_number] => 11/663495 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10109 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202571.pdf [firstpage_image] =>[orig_patent_app_number] => 11663495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777400 [patent_doc_number] => 20060106040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders' [patent_app_type] => utility [patent_app_number] => 11/234644 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11367 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106040.pdf [firstpage_image] =>[orig_patent_app_number] => 11234644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754841 [patent_doc_number] => 20060223990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Synthesis, deprotection, analysis & purification of RNA & ribozymes' [patent_app_type] => utility [patent_app_number] => 11/223720 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11927 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223990.pdf [firstpage_image] =>[orig_patent_app_number] => 11223720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794107 [patent_doc_number] => 20060014788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors' [patent_app_type] => utility [patent_app_number] => 11/222908 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46295 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014788.pdf [firstpage_image] =>[orig_patent_app_number] => 11222908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769650 [patent_doc_number] => 20060020128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Therapy-enhancing glucan' [patent_app_type] => utility [patent_app_number] => 11/218044 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 24248 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20060020128.pdf [firstpage_image] =>[orig_patent_app_number] => 11218044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5709974 [patent_doc_number] => 20060051319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Neuroprotective effect of solubilized UDCA in focal ischemic model' [patent_app_type] => utility [patent_app_number] => 11/215701 [patent_app_country] => US [patent_app_date] => 2005-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8746 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051319.pdf [firstpage_image] =>[orig_patent_app_number] => 11215701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625852 [patent_doc_number] => 20060264357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Capillary membrane stabilization and reduction of tissue injury through use of biodegradable macromolecules with antioxidants and/or other chemicals' [patent_app_type] => utility [patent_app_number] => 11/213303 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7039 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264357.pdf [firstpage_image] =>[orig_patent_app_number] => 11213303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895436 [patent_doc_number] => 20060003975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor' [patent_app_type] => utility [patent_app_number] => 11/206499 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14382 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003975.pdf [firstpage_image] =>[orig_patent_app_number] => 11206499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978782 [patent_doc_number] => 20050288500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-B-D-arabinofuranosyl)-9H-purin-6-amine' [patent_app_type] => utility [patent_app_number] => 11/204176 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4461 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288500.pdf [firstpage_image] =>[orig_patent_app_number] => 11204176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844520 [patent_doc_number] => 20060122208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid' [patent_app_type] => utility [patent_app_number] => 11/201024 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14502 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122208.pdf [firstpage_image] =>[orig_patent_app_number] => 11201024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515410 [patent_doc_number] => 20090215717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Sulfated oligosaccharides' [patent_app_type] => utility [patent_app_number] => 11/659300 [patent_app_country] => US [patent_app_date] => 2005-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5454 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215717.pdf [firstpage_image] =>[orig_patent_app_number] => 11659300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887489 [patent_doc_number] => 20080261821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Mechanism-Based Crosslinkers' [patent_app_type] => utility [patent_app_number] => 11/572082 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17637 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261821.pdf [firstpage_image] =>[orig_patent_app_number] => 11572082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931734 [patent_doc_number] => 20050282769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage' [patent_app_type] => utility [patent_app_number] => 11/183447 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4142 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282769.pdf [firstpage_image] =>[orig_patent_app_number] => 11183447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930799 [patent_doc_number] => 20050281833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Polysaccharide conjugates of biomolecules' [patent_app_type] => utility [patent_app_number] => 11/180245 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13558 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281833.pdf [firstpage_image] =>[orig_patent_app_number] => 11180245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250376 [patent_doc_number] => 20050272696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Methods of selectively treating diseases with specific glycosaminoglycan polymers' [patent_app_type] => utility [patent_app_number] => 11/172145 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 31117 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272696.pdf [firstpage_image] =>[orig_patent_app_number] => 11172145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769411 [patent_doc_number] => 20060019996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 11/166358 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12842 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019996.pdf [firstpage_image] =>[orig_patent_app_number] => 11166358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943566 [patent_doc_number] => 20110104186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Small molecule immunopotentiators and assays for their detection' [patent_app_type] => utility [patent_app_number] => 11/630550 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60502 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104186.pdf [firstpage_image] =>[orig_patent_app_number] => 11630550 [rel_patent_id] =>[rel_patent_doc_number] =>)